• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与内镜下黏膜切除术相比,内镜黏膜下剥离术治疗I型胃类癌肿瘤的有效性。

Usefulness of endoscopic submucosal dissection for type I gastric carcinoid tumors compared with endoscopic mucosal resection.

作者信息

Sato Yuichi, Takeuchi Manabu, Hashimoto Satoru, Mizuno Ken-ichi, Kobayashi Masaaki, Iwafuchi Mitsuya, Narisawa Rintaro, Aoyagi Yutaka

出版信息

Hepatogastroenterology. 2013 Sep;60(126):1524-9. doi: 10.5754/hge121185.

DOI:10.5754/hge121185
PMID:23933946
Abstract

BACKGROUND/AIMS: Gastric carcinoid tumors (GCTs) often extends into the submucosa, and are therefore difficult to resect completely by using conventional endoscopic mucosal resection (EMR). Endoscopic submucosal dissection (ESD) allows en bloc resection of submucosal gastrointestinal lesions. Therefore, ESD may be a feasible method for complete resection of GCT. Our purpose is to clarify the usefulness of ESD for treatment of type I GCT.

METHODOLOGY

Between 1998 and 2011, EMR or ESD was performed for 13 lesions in 12 patients with type I GCTs. Among the 13 GCTs, 6 were resected using EMR, and 7 were removed using ESD.

RESULTS

All lesions were histologically classified as Grade 1. The depth of invasion was the mucosa for 1 lesion and the submucosa for 12 lesions. The horizontal margins of excision were negative for all lesions; however, the vertical margins were positive in 4 lesions (66.7%) in the EMR group and no lesions (0%) in the ESD group.

CONCLUSIONS

The results of this study suggest that ESD for small type I GCT is better to achieve complete resection than conventional EMR. ESD would be an effective technique for the treatment of small type I GCT.

摘要

背景/目的:胃类癌肿瘤(GCTs)常浸润至黏膜下层,因此难以通过传统内镜黏膜切除术(EMR)完全切除。内镜黏膜下剥离术(ESD)可完整切除胃肠道黏膜下病变。因此,ESD可能是完全切除GCT的一种可行方法。我们的目的是阐明ESD治疗I型GCT的有效性。

方法

1998年至2011年期间,对12例I型GCT患者的13个病灶进行了EMR或ESD治疗。在这13个GCT中,6个采用EMR切除,7个采用ESD切除。

结果

所有病灶组织学分级均为1级。浸润深度为1个病灶局限于黏膜层,12个病灶浸润至黏膜下层。所有病灶切除的水平切缘均为阴性;然而,EMR组4个病灶(66.7%)的垂直切缘为阳性,ESD组无病灶(0%)垂直切缘阳性。

结论

本研究结果表明,对于小型I型GCT,ESD比传统EMR更能实现完全切除。ESD将是治疗小型I型GCT的有效技术。

相似文献

1
Usefulness of endoscopic submucosal dissection for type I gastric carcinoid tumors compared with endoscopic mucosal resection.与内镜下黏膜切除术相比,内镜黏膜下剥离术治疗I型胃类癌肿瘤的有效性。
Hepatogastroenterology. 2013 Sep;60(126):1524-9. doi: 10.5754/hge121185.
2
Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection.胃肿瘤内镜黏膜切除术的临床结果:内镜黏膜下剥离术与传统黏膜切除术的历史前瞻性评估
Gastrointest Endosc. 2006 May;63(6):776-82. doi: 10.1016/j.gie.2005.08.049.
3
Gastric mucosal cancer smaller than 7mm can be treated with conventional endoscopic mucosal resection as effectively as with endoscopic submucosal dissection.小于7毫米的胃黏膜癌采用传统内镜黏膜切除术治疗的效果与内镜黏膜下剥离术相同。
Hepatogastroenterology. 2010 May-Jun;57(99-100):668-73.
4
Resection area of 15 mm as dividing line for choosing strip biopsy or endoscopic submucosal dissection for mucosal gastric neoplasm.以15毫米的切除范围作为选择黏膜下胃肿瘤的条状活检或内镜黏膜下剥离术的分界线。
J Clin Gastroenterol. 2007 May-Jun;41(5):472-6. doi: 10.1097/01.mcg.0000247987.02677.b3.
5
[Endoscopic resection for early gastric cancers by EMR/ESD].[内镜下黏膜切除术/内镜黏膜下剥离术用于早期胃癌的切除]
Gan To Kagaku Ryoho. 2007 Jan;34(1):16-20.
6
Indications for the use of endoscopic mucosal resection for early gastric cancer in Japan: a comparative study with endoscopic submucosal dissection.日本早期胃癌内镜黏膜切除术的使用指征:与内镜黏膜下剥离术的比较研究
Endoscopy. 2009 Sep;41(9):746-50. doi: 10.1055/s-0029-1215010. Epub 2009 Aug 13.
7
Endoscopic submucosal dissection for treatment of rectal carcinoid tumors.内镜黏膜下剥离术治疗直肠类癌肿瘤。
Gastrointest Endosc. 2010 Jul;72(1):143-9. doi: 10.1016/j.gie.2010.01.040. Epub 2010 Apr 9.
8
Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study.1000例早期胃肿瘤内镜黏膜下剥离术的治疗结果:韩国ESD研究组多中心研究
Gastrointest Endosc. 2009 Jun;69(7):1228-35. doi: 10.1016/j.gie.2008.09.027. Epub 2009 Feb 27.
9
The feasibility of endoscopic submucosal dissection for rectal carcinoid tumors: comparison with endoscopic mucosal resection.内镜黏膜下剥离术治疗直肠类癌的可行性:与内镜黏膜切除术的比较。
Endoscopy. 2010 Aug;42(8):647-51. doi: 10.1055/s-0030-1255591. Epub 2010 Jul 28.
10
A new technique for gastric endoscopic submucosal dissection: peroral traction-assisted endoscopic submucosal dissection.一种新的胃内镜黏膜下剥离术:经口牵引辅助内镜黏膜下剥离术。
Gastrointest Endosc. 2009 Jan;69(1):29-33. doi: 10.1016/j.gie.2008.03.1126.

引用本文的文献

1
Predictors of Outcomes in Gastric Neuroendocrine Tumors: A Retrospective Cohort.胃神经内分泌肿瘤预后的预测因素:一项回顾性队列研究
GE Port J Gastroenterol. 2023 Jul 14;31(4):236-245. doi: 10.1159/000530684. eCollection 2024 Aug.
2
Personalized treatment of well-differentiated gastric neuroendocrine tumors based on clinicopathological classification and grading: A multicenter retrospective study.基于临床病理分类和分级的胃神经内分泌肿瘤的个体化治疗:一项多中心回顾性研究。
Chin Med J (Engl). 2024 Mar 20;137(6):720-728. doi: 10.1097/CM9.0000000000003029. Epub 2024 Feb 22.
3
Management of Gastric Neuroendocrine Tumors: A Review.
胃神经内分泌肿瘤的治疗:综述。
Ann Surg Oncol. 2024 Mar;31(3):1509-1518. doi: 10.1245/s10434-023-14712-9. Epub 2023 Dec 7.
4
Role of Advanced Gastrointestinal Endoscopy in the Comprehensive Management of Neuroendocrine Neoplasms.高级胃肠内镜检查在神经内分泌肿瘤综合管理中的作用
Cancers (Basel). 2023 Aug 19;15(16):4175. doi: 10.3390/cancers15164175.
5
Endoscopic techniques for gastric neuroendocrine tumors: An update.胃神经内分泌肿瘤的内镜技术:最新进展
World J Gastrointest Endosc. 2023 Mar 16;15(3):103-113. doi: 10.4253/wjge.v15.i3.103.
6
Clinical characteristics and long-term prognosis of type 1 gastric neuroendocrine tumors in a large Japanese national cohort.日本大型全国队列中1型胃神经内分泌肿瘤的临床特征及长期预后
Dig Endosc. 2023 Sep;35(6):757-766. doi: 10.1111/den.14529. Epub 2023 Mar 28.
7
Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms.胃肠胰神经内分泌肿瘤的内镜诊治、治疗和当前概念。
World J Gastroenterol. 2022 Sep 14;28(34):4943-4958. doi: 10.3748/wjg.v28.i34.4943.
8
Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter.直径小于 10 毫米的 I 型胃神经内分泌肿瘤单独进行内镜监测是可行且安全的。
Endocrine. 2022 Oct;78(1):186-196. doi: 10.1007/s12020-022-03143-3. Epub 2022 Jul 27.
9
Endoscopic Mucosal Resection: Best Practices for Gastrointestinal Endoscopists.内镜黏膜切除术:胃肠内镜医师的最佳实践
Gastroenterol Hepatol (N Y). 2022 Mar;18(3):133-144.
10
Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives.胃肠胰神经内分泌肿瘤的治疗策略:现状与未来展望
World J Gastrointest Surg. 2022 Feb 27;14(2):78-106. doi: 10.4240/wjgs.v14.i2.78.